In a patient with isolated metabolic alkalosis (serum bicarbonate 33 mEq/L) and mildly elevated blood urea nitrogen (23 mg/dL), with all other electrolytes within normal limits and only taking captopril, what is the next step in management?

Assess Urine Chloride to Determine the Cause of Metabolic Alkalosis

In a patient with isolated metabolic alkalosis (CO2 33 mEq/L) on captopril with mildly elevated BUN (23 mg/dL), the next step is to measure urine chloride to distinguish between chloride-responsive (volume depletion) and chloride-resistant (mineralocorticoid excess) causes. 1

Clinical Context and Pathophysiology

This patient presents with metabolic alkalosis (serum bicarbonate 33 mEq/L) while taking captopril, an ACE inhibitor. The mildly elevated BUN (23 mg/dL) with normal other electrolytes suggests possible volume contraction. Metabolic alkalosis requires both generation (gain of bicarbonate or loss of acid) and maintenance factors (volume contraction, hypokalemia, hypochloremia, or aldosterone excess) 1, 2.

Diagnostic Algorithm

Step 1: Measure Urine Chloride

• Urine chloride <20 mEq/L indicates chloride-responsive alkalosis (volume depletion, vomiting, diuretic use)
• Urine chloride >20 mEq/L indicates chloride-resistant alkalosis (mineralocorticoid excess, severe hypokalemia) 1

Step 2: Assess Volume Status

Examine for:

• Orthostatic vital signs
• Jugular venous pressure
• Skin turgor and mucous membranes
• Peripheral edema

Step 3: Check Additional Labs

• Serum potassium (if not already done)
• Serum chloride
• Urine sodium
• Blood pressure measurement

Management Based on Findings

If Chloride-Responsive (Urine Cl <20 mEq/L):

Volume repletion with normal saline is the primary treatment. 1, 2 The captopril may be contributing to volume contraction through reduced aldosterone and subsequent sodium loss. Consider:

1. Administer 0.9% NaCl intravenously if symptomatic or severe
2. Temporarily reduce or hold captopril if blood pressure allows 3
3. Monitor electrolytes closely during repletion

If Chloride-Resistant (Urine Cl >20 mEq/L):

Investigate for:

• Primary aldosteronism (perform captopril challenge test or plasma aldosterone/renin ratio) 4
• Renovascular hypertension (though captopril would typically help this)
• Licorice ingestion or exogenous mineralocorticoid use

ACE Inhibitor Considerations

Captopril itself does not typically cause metabolic alkalosis—in fact, ACE inhibitors reduce aldosterone and should theoretically prevent alkalosis. 3 However, if the patient has:

• Volume depletion from dietary sodium restriction (common with ACE inhibitor therapy)
• Concurrent diuretic use (even if recently discontinued)
• Vomiting or GI losses (not mentioned but should be excluded)

The captopril dosing may need adjustment. Per FDA labeling, captopril should be used cautiously in volume-depleted patients, with initial doses of 6.25-12.5 mg TID in such cases 3.

Monitoring Parameters

After initiating treatment:

• Recheck electrolytes in 2-3 days, then at 7 days 5
• Monitor blood pressure closely
• Assess for resolution of alkalosis (target bicarbonate <30 mEq/L)
• If captopril was held, restart cautiously once volume status normalized

Critical Pitfalls to Avoid

1. Do not administer potassium-sparing diuretics (like spironolactone) without first correcting volume status and confirming the diagnosis, as this could cause dangerous hyperkalemia with ACE inhibitor therapy 6, 5

2. Avoid aggressive bicarbonate correction if pH <7.55 and patient is asymptomatic—the body will self-correct once maintenance factors are addressed 1

3. Do not assume captopril is the cause without excluding other common etiologies like occult vomiting, prior diuretic use, or dietary factors

4. Monitor for worsening renal function during volume repletion, as the BUN elevation may worsen transiently before improving 3

The urine chloride measurement is the single most important next step to guide appropriate therapy in this clinical scenario.